Literature DB >> 11196675

Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10).

G Gallagher1, H Dickensheets, J Eskdale, L S Izotova, O V Mirochnitchenko, J D Peat, N Vazquez, S Pestka, R P Donnelly, S V Kotenko.   

Abstract

Interleukin-10 (IL-10) is a pleiotropic cytokine with important immunoregulatory functions whose actions influence activities of many of the cell-types in the immune system. We report here identification and cloning of a gene and corresponding cDNAs encoding a novel homologue of IL-10, designated IL-19. IL-19 shares 21% amino acid identity with IL-10. The exon/intron structure of IL-19 is similar to that of the human IL-10 gene, comprising five exons and four introns within the coding region of the IL-19 cDNA. There are at least two distinct IL-19 mRNA species that differ in their 5'-sequences, suggesting the existence of an intron in the 5'-sequences of coding portion of the IL-19 gene. The longer 5'-sequence contains an alternative initiating ATG codon that is in-frame with the rest of the coding sequence. The expression of IL-19 mRNA can be induced in monocytes by LPS-treatment. The appearance of IL-19 mRNA in LPS-stimulated monocytes was slightly delayed compared to expression of IL-10 mRNA: significant levels of IL-10 mRNA were detectable at 2 h post-stimulation, whereas IL-19 mRNA was not detectable until 4 h. Treatment of monocytes with IL-4 or IL-13 did not induce de novo expression of IL-19, but these cytokines did potentiate IL-19 gene expression in LPS-stimulated monocytes. In addition, GM-CSF was capable of directly inducing IL-19 gene expression in monocytes. IL-19 does not bind or signal through the canonical IL-10 receptor complex, suggesting existence of an IL-19 specific receptor complex, the identity of which remains to be discovered.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11196675     DOI: 10.1038/sj.gene.6363714

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  79 in total

1.  Il-19 reduces VSMC activation by regulation of mRNA regulatory factor HuR and reduction of mRNA stability.

Authors:  Anthony A Cuneo; David Herrick; Michael V Autieri
Journal:  J Mol Cell Cardiol       Date:  2010-05-06       Impact factor: 5.000

Review 2.  Structure and function of interleukin-22 and other members of the interleukin-10 family.

Authors:  Daniela Barretto Barbosa Trivella; José Ribamar Ferreira-Júnior; Laure Dumoutier; Jean-Christophe Renauld; Igor Polikarpov
Journal:  Cell Mol Life Sci       Date:  2010-05-08       Impact factor: 9.261

3.  The Ets transcription factor EHF as a regulator of cornea epithelial cell identity.

Authors:  Denise N Stephens; Rachel Herndon Klein; Michael L Salmans; William Gordon; Hsiang Ho; Bogi Andersen
Journal:  J Biol Chem       Date:  2013-10-18       Impact factor: 5.157

4.  Interleukin-19 induces angiogenesis in the absence of hypoxia by direct and indirect immune mechanisms.

Authors:  Farah Kako; Khatuna Gabunia; Mitali Ray; Sheri E Kelemen; Ross N England; Bashar Kako; Rosario G Scalia; Michael V Autieri
Journal:  Am J Physiol Cell Physiol       Date:  2016-04-06       Impact factor: 4.249

5.  Interleukin-20 receptor expression in the trabecular meshwork and its implication in glaucoma.

Authors:  Kate E Keller; Yong-Feng Yang; Ying Ying Sun; Renee Sykes; Natalie Donna Gaudette; John R Samples; Ted S Acott; Mary K Wirtz
Journal:  J Ocul Pharmacol Ther       Date:  2014-01-23       Impact factor: 2.671

6.  IL-22 suppresses HSV-2 replication in human cervical epithelial cells.

Authors:  Xi-Qiu Xu; Yu Liu; Biao Zhang; Hang Liu; Dan-Dan Shao; Jin-Biao Liu; Xu Wang; Li-Na Zhou; Wen-Hui Hu; Wen-Zhe Ho
Journal:  Cytokine       Date:  2019-07-22       Impact factor: 3.861

7.  IL-19 reduces ligation-mediated neointimal hyperplasia by reducing vascular smooth muscle cell activation.

Authors:  Stephen Ellison; Khatuna Gabunia; James M Richards; Sheri E Kelemen; Ross N England; Dan Rudic; Yasu-Taka Azuma; M Alexandra Munroy; Satoru Eguchi; Michael V Autieri
Journal:  Am J Pathol       Date:  2014-05-09       Impact factor: 4.307

8.  IL-19 Halts Progression of Atherosclerotic Plaque, Polarizes, and Increases Cholesterol Uptake and Efflux in Macrophages.

Authors:  Khatuna Gabunia; Stephen Ellison; Sheri Kelemen; Farah Kako; William D Cornwell; Thomas J Rogers; Prasun K Datta; Mireille Ouimet; Kathryn J Moore; Michael V Autieri
Journal:  Am J Pathol       Date:  2016-03-04       Impact factor: 4.307

Review 9.  Expression and function of anti-inflammatory interleukins: the other side of the vascular response to injury.

Authors:  Anthony A Cuneo; Michael V Autieri
Journal:  Curr Vasc Pharmacol       Date:  2009-07       Impact factor: 2.719

10.  Interleukin-19 contributes as a protective factor in experimental Th2-mediated colitis.

Authors:  Yasuyuki Fujimoto; Yasu-Taka Azuma; Yukiko Matsuo; Mitsuru Kuwamura; Nobuyuki Kuramoto; Mariko Miki; Naoki Azuma; Midori Teramoto; Kazuhiro Nishiyama; Takeshi Izawa; Hidemitsu Nakajima; Tadayoshi Takeuchi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.